| pubmed-article:8172743 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C0262950 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C0153690 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C0817214 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C0039416 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
| pubmed-article:8172743 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:8172743 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8172743 | pubmed:dateCreated | 1994-6-6 | lld:pubmed |
| pubmed-article:8172743 | pubmed:abstractText | Although bone scintigraphy with 99mTc-MDP is a sensitive diagnostic method to detect bone metastasis, it is not specific for malignancy. A radioactive substance which accumulates specifically into metastatic lesions should be of value. 123I-IMP and bone scintigraphy with 99mTc-MDP were consecutively performed in patients with vertebral bone metastases from hepatocellular carcinoma and lumbar spondylosis deformans in a 7-day interval or shorter. The intensity of uptake was compared. Eighteen of the 20 metastatic lesions (90%) were classified as increased uptake areas in 123I-IMP scintigraphy. MDP-scintigraphy disclosed 16 metastatic lesions (80%), 9 as "hot" lesions (56%) and 7 as "cold" lesions (44%). 123I-IMP scintigraphy was negative in all 12 lesions of lumbar spondylosis deformans. Compared to MDP-scintigraphy, 123I-IMP scintigraphy was more sensitive in detecting vertebral bone metastases of hepatocellular carcinoma with smaller rates of false-positive and false-negative findings. | lld:pubmed |
| pubmed-article:8172743 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8172743 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8172743 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8172743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8172743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8172743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8172743 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8172743 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8172743 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:8172743 | pubmed:issn | 0284-1851 | lld:pubmed |
| pubmed-article:8172743 | pubmed:author | pubmed-author:OhtaYY | lld:pubmed |
| pubmed-article:8172743 | pubmed:author | pubmed-author:TanigawaNN | lld:pubmed |
| pubmed-article:8172743 | pubmed:author | pubmed-author:SutoYY | lld:pubmed |
| pubmed-article:8172743 | pubmed:author | pubmed-author:IwamiyaTT | lld:pubmed |
| pubmed-article:8172743 | pubmed:author | pubmed-author:ShabanaMM | lld:pubmed |
| pubmed-article:8172743 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8172743 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:8172743 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8172743 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8172743 | pubmed:pagination | 159-63 | lld:pubmed |
| pubmed-article:8172743 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:meshHeading | pubmed-meshheading:8172743-... | lld:pubmed |
| pubmed-article:8172743 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8172743 | pubmed:articleTitle | Clinical experience of 123I-IMP scintigraphy in detecting vertebral bone metastases of hepatocellular carcinoma. A comparison with bone scintigraphy with 99mTc-MDP. | lld:pubmed |
| pubmed-article:8172743 | pubmed:affiliation | Department of Radiology, Tottori University Faculty of Medicine, Yonago, Japan. | lld:pubmed |
| pubmed-article:8172743 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8172743 | pubmed:publicationType | Comparative Study | lld:pubmed |
